These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30255931)

  • 1. Variants p.Q1236H and p.E1143G in mitochondrial DNA polymerase gamma POLG1 are not associated with increased risk for valproate-induced hepatotoxicity or pancreatic toxicity: A retrospective cohort study of patients with epilepsy.
    Hynynen J; Pokka T; Komulainen-Ebrahim J; Myllynen P; Kärppä M; Pylvänen L; Kälviäinen R; Sokka A; Jyrkilä A; Lähdetie J; Haataja L; Mäkitalo A; Ylikotila P; Eriksson K; Haapala P; Ansakorpi H; Hinttala R; Vieira P; Majamaa K; Rantala H; Uusimaa J
    Epilepsia; 2018 Nov; 59(11):2125-2136. PubMed ID: 30255931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute liver failure after valproate exposure in patients with POLG1 mutations and the prognosis after liver transplantation.
    Hynynen J; Komulainen T; Tukiainen E; Nordin A; Arola J; Kälviäinen R; Jutila L; Röyttä M; Hinttala R; Majamaa K; Mäkisalo H; Uusimaa J
    Liver Transpl; 2014 Nov; 20(11):1402-12. PubMed ID: 25065347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooccurrence of Two Different Genetic Diseases: A Case of Valproic Acid Hepatotoxicity in Nicolaides-Baraitser Syndrome (SMARCA2 Mutation)-Due to a POLG1-Related Effect?
    Hofmeister B; von Stülpnagel C; Berweck S; Abicht A; Kluger G; Weber P
    Neuropediatrics; 2020 Feb; 51(1):49-52. PubMed ID: 31541998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of age and polytherapy, risk factors of valproic acid (VPA) hepatotoxicity, on the excretion of thiol conjugates of (E)-2,4-diene VPA in people with epilepsy taking VPA.
    Gopaul S; Farrell K; Abbott F
    Epilepsia; 2003 Mar; 44(3):322-8. PubMed ID: 12614387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymerase γ gene POLG determines the risk of sodium valproate-induced liver toxicity.
    Stewart JD; Horvath R; Baruffini E; Ferrero I; Bulst S; Watkins PB; Fontana RJ; Day CP; Chinnery PF
    Hepatology; 2010 Nov; 52(5):1791-6. PubMed ID: 21038416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of CYP2C9 and CYP2A6 Polymorphisms with the Concentrations of Valproate and its Hepatotoxin Metabolites and Valproate-Induced Hepatotoxicity.
    Zhao M; Zhang T; Li G; Qiu F; Sun Y; Zhao L
    Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):138-143. PubMed ID: 28273397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase gamma (POLG1).
    McFarland R; Hudson G; Taylor RW; Green SH; Hodges S; McKiernan PJ; Chinnery PF; Ramesh V
    Arch Dis Child; 2008 Feb; 93(2):151-3. PubMed ID: 18208989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid for myoclonic epilepsy in POLG1 carriers can be fatal.
    Finsterer J
    Folia Neuropathol; 2021; 59(1):17-18. PubMed ID: 33969673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Carbamazepine and Valproate on Serum Aspartate Aminotransferase, Alanine Aminotransferase and Gamma - Glutamyltransferase in Children.
    Hadzagic-Catibusic F; Hasanbegovic E; Melunovic M; Zubcevic S; Uzicanin S
    Med Arch; 2017 Aug; 71(4):239-242. PubMed ID: 28974841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Valproic Acid-induced Hyperammonaemia in Chinese Paediatric Patients with Epilepsy.
    Zhu X; Li X; Zhang T; Zhao L
    Basic Clin Pharmacol Toxicol; 2018 Nov; 123(5):628-634. PubMed ID: 29791065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders.
    Saneto RP; Lee IC; Koenig MK; Bao X; Weng SW; Naviaux RK; Wong LJ
    Seizure; 2010 Apr; 19(3):140-6. PubMed ID: 20138553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is 2-propyl-4-pentenoic acid, a hepatotoxic metabolite of valproate, responsible for valproate-induced hyperammonemia?
    Kondo T; Ishida M; Kaneko S; Hirano T; Otani K; Fukushima Y; Muranaka H; Koide N; Yokoyama M; Nakata S
    Epilepsia; 1992; 33(3):550-4. PubMed ID: 1350534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Valproic acid-induced idiosyncratic liver injury in 4 cases].
    Xiong H; Liu CT; Zhang YH; Bao XH; Jiang YW; Zhao H; Wu XP; Qin J
    Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):890-4. PubMed ID: 23324142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Children versus adults: pharmacokinetic and adverse-effect differences.
    Anderson GD
    Epilepsia; 2002; 43 Suppl 3():53-9. PubMed ID: 12060006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease in adolescents receiving valproic acid.
    Verrotti A; Agostinelli S; Parisi P; Chiarelli F; Coppola G
    Epilepsy Behav; 2011 Feb; 20(2):382-5. PubMed ID: 21256090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproate metabolites in high-dose valproate plus phenytoin therapy.
    Sugimoto T; Muro H; Woo M; Nishida N; Murakami K
    Epilepsia; 1996 Dec; 37(12):1200-3. PubMed ID: 8956852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulforaphane protects against sodium valproate-induced acute liver injury.
    Nazmy EA; El-Khouly OA; Atef H; Said E
    Can J Physiol Pharmacol; 2017 Apr; 95(4):420-426. PubMed ID: 28112972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA polymerase gamma variants and hepatotoxicity during maintenance therapy of childhood acute lymphoblastic leukemia: is there a causal relationship?
    Harju T; Hurme-Niiranen A; Suo-Palosaari M; Nygaard Nielsen S; Hinttala R; Schmiegelow K; Uusimaa J; Harila A; Niinimäki R
    Pharmacogenomics J; 2023 Sep; 23(5):105-111. PubMed ID: 37138020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic Acid and the Liver Injury in Patients with Epilepsy: An Update.
    Guo HL; Jing X; Sun JY; Hu YH; Xu ZJ; Ni MM; Chen F; Lu XP; Qiu JC; Wang T
    Curr Pharm Des; 2019; 25(3):343-351. PubMed ID: 30931853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Valproic Acid and Its Main Metabolites' Plasma Concentrations with Clinical Outcomes among Epilepsy Patients: A 10-Year Retrospective Study Based on Therapeutic Drug Monitoring.
    Li RT; Chen ZY; Tang SY; Wen DS; Ren RN; Zhang XX; Liu SZ; Zhou S; Wang XD; Zhou LM; Huang M
    Drug Metab Dispos; 2024 Feb; 52(3):210-217. PubMed ID: 38195521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.